We are thrilled to announce that the APS Type 1 Foundation has won a $50,000 grant for general operating support from the Chan Zuckerberg Donor Advised Fund (DAF), through the Silicon Valley Community Foundation (SVCF). This grant is a game-changer for our Foundation and we owe special thanks to our Medical Advisory Committee for their grant writing support.
We are determined to use the grant to improve our operating capacity on a number of fronts. In that vein, we are excited to announce that the Foundation has retained The Park Group to support patient and family engagement, social media and communications and to continue development of our registry and physician/scientist network. Many of you will have met Tina Park at our virtual symposium in September. The Park Group provides incredible depth in communications, outreach and event management. We are excited to benefit from Dr. Park and her colleagues’ expertise as we work to build a global community of APS Type 1 patients and physician scientists who together will work for better treatments and ultimately a cure.